TAKEDA PHARMACEUTICAL innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	EPO (European Patent Office)	773
#2	United States	637
#3	WIPO (World Intellectual Property Organization)	624
#4	Canada	245
#5	China	221
#6	Republic of Korea	220
#7	Taiwan	175
#8	Argentina	174
#9	Peru	163
#10	Israel	137
#11	Costa Rica	124
#12	Mexico	123
#13	New Zealand	107
#14	Brazil	106
#15	Morocco	96
#16	Uruguay	94
#17	Norway	85
#18	Dominican Republic	81
#19	United Kingdom	78
#20	Colombia	77
#21	Singapore	74
#22	Ecuador	72
#23	Hong Kong	63
#24	South Africa	61
#25	Tunisia	60
#26	Chile	55
#27	Malaysia	54
#28	Georgia	42
#29	EAPO (Eurasian Patent Organization)	41
#30	Ukraine	40
#31	Germany	39
#32	Switzerland	30
#33	Serbia	25
#34	Hungary	23
#35	Poland	23
#36	African Regional Industrial Property Organization	20
#37	Australia	12
#38	France	7
#39	Jordan	7
#40	Luxembourg	7
#41	Philippines	7
#42	Slovakia	7
#43	Czechia	5
#44	India	4
#45	Cyprus	2
#46	Denmark	2
#47	Finland	2
#48	Guatemala	2
#49	Netherlands	2
#50	African Intellectual Property Organization	2
#51	Spain	1
#52	Honduras	1
#53	Croatia	1
#54	Iceland	1
#55	Montenegro	1
#56	Panama	1

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Peptides
#5	Acyclic or carbocyclic compounds
#6	Analysing materials
#7	Special acyclic compounds
#8	Microorganisms
#9	Unspecified technologies
#10	Measuring microorganism processes

Publication	Filing date	Title
GB201601301D0	2016-01-25	Novel compounds
CN106999676A	2015-12-17	Inject needle guard
WO2016088903A1	2015-12-04	Heterocyclic compounds
GB201521015D0	2015-11-27	Novel pharmaceutical uses
TW201629071A	2015-10-16	Fused heterocyclic compound
CN106795172A	2015-09-29	The crystal formation of 1 (base of 1 methyl 1H pyrazoles 4) N (base of 3 oxa- of (1R, 5S, 7S) 9 methyl 9 azabicyclo [3.3.1] nonyl 7) formamide of 1H indoles 3
WO2016047678A1	2015-09-24	Heterocyclic compound
WO2016039408A1	2015-09-10	Heterocyclic compound
TW201625799A	2015-09-04	Method for treating depression and major depressive disorder
WO2016031815A1	2015-08-25	Heterocyclic compound
WO2016021742A1	2015-08-06	Heterocyclic compounds as ep4 receptor antagonists
WO2016002968A1	2015-06-30	Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors
GB201510241D0	2015-06-12	Animal model
WO2015174534A1	2015-05-15	Nitrogen-containing heterocyclic compound
UY36071A	2015-04-09	CYCLOPROPANAMINE COMPOUND AND ITS USES
GB201505526D0	2015-03-31	Novel pharmaceutical uses
WO2015146929A1	2015-03-23	Heterocyclic compound
WO2015146928A1	2015-03-23	Heterocyclic compound
GB201504565D0	2015-03-18	Novel compounds
CN106232144A	2015-03-17	Solid dispersion